Back to Search
STEPHEN NAYLOR, DO
DO
Family Medicine Physician
NPI: 1851332472IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
OS019500(PA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Class of 1996
Research & Publications (20)
Towards a systems level analysis of health and nutrition.
PMID 18387294·Curr Opin Biotechnol·2008
6-review
Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host.
PMID 12595469·Infect Immun·2003
7-preclinical
Retroviral expression of Wnt-1 and Wnt-7b produces different effects in mouse mammary epithelium.
PMID 10825286·J Cell Sci·2000
7-preclinical
Symptom classification in irritable bowel syndrome as a guide to treatment.
PMID 19452358·Scand J Gastroenterol·2009
8-other
The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality.
PMID 19242354·Crit Care Med·2009
8-other
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.
PMID 19128501·J Transl Med·2009
3-trial
Vaccination of patients with metastatic renal cancer with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax) given alongside interferon-alpha.
PMID 19342962·J Immunother·2009
3-trial
Severity of meningococcal disease associated with genomic bacterial load.
PMID 19191644·Clin Infect Dis·2009
8-other
Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons.
PMID 19503091·Nat Genet·2009
7-preclinical
Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trial.
PMID 19561532·J Immunother·2009
3-trial
A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis.
PMID 19208652·Hum Mol Genet·2009
7-preclinical
Cisplatin and dimethyl sulfoxide react to form an adducted compound with reduced cytotoxicity and neurotoxicity.
PMID 18439683·Neurotoxicology·2008
7-preclinical
Escherichia coli O157:H7 colonization in cattle following systemic and mucosal immunization with purified H7 flagellin.
PMID 18362130·Infect Immun·2008
2-rct
KBP is essential for axonal structure, outgrowth and maintenance in zebrafish, providing insight into the cellular basis of Goldberg-Shprintzen syndrome.
PMID 18192286·Development·2008
7-preclinical
Association of polymorphisms in TGFB1 and prostate cancer prognosis.
PMID 18082198·J Urol·2008
8-other
Vaccination of renal cell cancer patients with modified vaccinia ankara delivering tumor antigen 5T4 (TroVax) administered with interleukin 2: a phase II trial.
PMID 19010868·Clin Cancer Res·2008
3-trial
Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy.
PMID 18463687·Gene Ther·2008
7-preclinical
Pathogenic potential of emergent sorbitol-fermenting Escherichia coli O157:NM.
PMID 18852247·Infect Immun·2008
7-preclinical
Responses of cattle to gastrointestinal colonization by Escherichia coli O157:H7.
PMID 18765741·Infect Immun·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 455 WOODVIEW RD STE 100
WEST GROVE, PA 19390 - Phone
- (610) 345-1900
Quick Facts
- NPI
- 1851332472
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile